Cancer Diagnosis
Early Detection of Several Types of Cancer
LIVER CANCER...
700.000
NEW CASES EVERY YEAR
50%
80%
CURED IF EARLY DIAGNOSED
DIE
OUR PRODUCTS
yliver is a blood test that detects alpha-fetoprotein autoantibodies. Taby diagnostics provides this test to hospitals and associated laboratories to early diagnose liver cancer with a sensitivity of 100% and a specificity of 94%
OUR TECHNOLOGY
Taby diagnostics tecnhology increases the immunogenicity of tumor-associated antigens
1
2
3
Applying Taby technology to modify the tumor-associated antigen (TAA)
Sensitizing plate with modified TAA
Immunoassy with our IVD kit using serum
Co-founder & CEO
XAVIER GALLEGO
PhD in Biology with an entrepreneurial mindset and wide experience on project management, innovation, and technology transfer.
Co-founder & CMO
JUAN Fco DELGADO
Medical doctor specialist in immunology with 10 years of experience in clinical practice. Expert on tumor-associated antigens autoantibodies.
ABOUT US
Taby diagnostics is a spin-off of Parc Taulí University Hospital. Its mission is to provide the society with a tool to early diagnose several types of cancer.
SPONSORS
CONTACT US
Parc Taulí, 1
Sabadell, 08208
Spain